SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001387131-20-001277
Filing Date
2020-02-11
Accepted
2020-02-11 12:57:33
Documents
1
Group Members
DAVID C. OTTO. ANDREAS HALVORSENROSE S. SHABETVIKING GLOBAL OPPORTUNITIES GP LLCVIKING GLOBAL OPPORTUNITIES ILLIQUID INVESTMENTS SUB-MASTER LPVIKING GLOBAL OPPORTUNITIES LIQUID PORTFOLIO SUB-MASTER LPVIKING GLOBAL OPPORTUNITIES PORTFOLIO GP LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM SC 13G eidos-sc13ga_123119.htm SC 13G/A 217079
  Complete submission text file 0001387131-20-001277.txt   218910
Mailing Address 55 RAILROAD AVENUE GREENWICH CT 06830
Business Address 55 RAILROAD AVENUE GREENWICH CT 06830 212-672-7050
VIKING GLOBAL INVESTORS LP (Filed by) CIK: 0001103804 (see all company filings)

IRS No.: 134055118 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104
Business Address 101 MONTGOMERY STREET, SUITE 2550 SAN FRANCISCO CA 94104 650-391-9740
Eidos Therapeutics, Inc. (Subject) CIK: 0001731831 (see all company filings)

IRS No.: 463733671 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90540 | Film No.: 20595553
SIC: 2834 Pharmaceutical Preparations